The Baltics Today

Grindeks sees 22% reduction in turnover in Q1

On Friday, joint-stock pharmaceutical company Grindeks submitted its non-audited consolidated financial statements for the first quarter of 2014 to the NASDAQ OMX Riga stock exchange, cites LETA/Nozare.lv.... Read more...

Comments are closed.